ERBB2 and triple-negative breast carcinoma: Especially, the basal-like subtype, often referred to as triple-negative breast cancer (TNBC) owing to its absence of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2) expression, is of particular concern (Bianchini et al. 2022).